Catalent
CTLT
#1815
Rank
โ‚น1.114 T
Marketcap
โ‚น6,140
Share price
0.00%
Change (1 day)
24.00%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): -โ‚น527.16

According to Catalent's latest financial reports the company's current EPS (TTM) is -โ‚น612.30. In 2023 the company made an earnings per share (EPS) of -โ‚น657.76 a decrease over its 2022 EPS that were of โ‚น219.58.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-โ‚น527.16-19.86%
2023-โ‚น657.76-399.56%
2022โ‚น219.58-30.58%
2021โ‚น316.3179.67%
2020โ‚น176.05114.12%
2019โ‚น82.22-15%
2018โ‚น96.7375.44%
2017โ‚น55.14-22.97%
2016โ‚น71.58-59.56%
2015โ‚น177.02282.05%
2014โ‚น46.33

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
-โ‚น185.72-69.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
โ‚น1,475-340.92%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
-โ‚น72.55-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
-โ‚น143.16-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA